Broadcom's stock has seen a dramatic decline of almost 22% from its recent high in December 2024, driven by escalating market fears due to trade wars between the U.S. and China. Yet, the stock remains ...

Three Motley Fool contributors think they've found no-brainer healthcare stocks to buy in May. Here's why they picked Eli ...

Berkshire Hathaway’s Class B shares fall after Warren Buffett says he’ll be stepping down as CEO at the end of the year, ...

The Fed will announce its decision on interest rates on Wednesday. And it’s another crowded week for earnings, with reports ...

The premise is that stock market returns are often lower between May and October than from November to April. Here are five ...

Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) will be announcing earnings results tomorrow afternoon. Here’s what ...

A solar-storage power station in a desert region of northwestern China, deploying 1.3GW of Trinasolar Vertex N modules, has ...

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with ...

Gilead (GILD) stock and Vertex Pharma (VRTX) stock are said to be relatively immune to Trump administration's tariffs threats ...

Amid a reckoning for the gene therapy field, Vertex Pharmaceuticals has joined a growing list of companies paring back their ...

A recent decision from the United States District Court for the District of Columbia continues to give significant deference ...

This pullback is completely natural, as the USDX just completed its inverse head-and-shoulders pattern. Corrections after ...